Kristin Klaeske

Dr. Kristin Klaeske

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2019 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
KKKristin Klaeske
Kristin Klaeske
MDMaja-Theresa Dieterlen
Maja-Theresa Dieterlen
USUte Scholz
Ute Scholz
SLSven Lehmann
Sven Lehmann
JGJens Garbade
Jens Garbade
AMAnna Meyer
Anna Meyer
OBJECTIVES: The acquired von Willebrand syndrome (AvWS), which is associated with left ventricular assist device support, is caused by the loss of the von Willebrand factor (vWF) high molecular weight multimers (HMWMs). We investigated whether the implantation of the left ventricular assist device HeartMate 3 (HM 3) is superior to the HeartWare ventricular assist device (HVAD) in preserving the multimeric structure of vWF. METHODS: In total, 70 patients with implanted HM 3 (n = 35) or HVAD (n = 35) were retrospectively investigated. HMWMs, intermediate molecular weight multimers and low molecular weight multimers were quantified by using a densitometric methodology. vWF antigen, vWF activity and vWF collagen-binding activity, as well as demographic and clinical data, were analysed. RESULTS: AvWS, which is characterized by a decrease in vWF HMWMs, was found in 97.1% of patients in the HM 3 group and 100% of patients in the HVAD group. Compared to normal pooled plasma, HM 3 induced a reduction in HMWMs (40.7 ± 8.2% vs 26.7 ± 7.5%, P < 0.01) and an increase in low molecular weight multimers (31.3 ± 11.8% vs 42.7 ± 9.8%, P < 0.01), whereas HVAD patients exhibited an increase in the percentage of intermediate molecular weight multimers (28.0 ± 5.0% vs 38.4 ± 7.7%, P < 0.01) in addition to a decrease in the percentage of HMWM (23.0 ± 11.0%, P < 0.01). A comparison of both left ventricular assist device types showed a difference in vWF multimeric structure (HMWMs: P < 0.01, intermediate molecular weight multimer: P = 0.05, low molecular weight multimer: P = 0.03). Furthermore, vWF activity was elevated in patients with an implanted HM 3 device (153.7 ± 54.4%) compared to those with an HVAD device (126.3 ± 39.7%, P = 0.02). CONCLUSIONS: Patients with an implanted HM 3 had more intact HMWMs and a higher vWF activity during device support. This may reduce the manifestation of AvWS in HM 3 patients and could thus lead to a lower bleeding complication rate.

26 February 2021 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
KKKristin Klaeske
Kristin Klaeske
MDMaja‐Theresa Dieterlen
Maja‐Theresa Dieterlen
SESandra Eifert
Sandra Eifert
USUte Scholz
Ute Scholz
JGJens Garbade
Jens Garbade
AMAnna L. Meyer
Anna L. Meyer
Background Non‐surgical bleeding (NSB) is a major complication after left ventricular assist device (LVADs) implantation. It has been reported that non‐physiological shear stress caused by LVADs could altered platelet receptor expression, which leads to bleeding disorders caused by coagulation dysfunctions. Objectives Because bleeding diathesis could be multifactorial, we focused on the combined characterization of platelet receptor expression patterns and oxidative stress to compare patients with NSB and patients without coagulation disorder in a monocentric, prospective study. Methods Blood samples were obtained from LVAD patients with NSB (bleeder group,n=19) and without NSB (non‐bleeder group,n=20). The platelet receptors platelet endothelial cell adhesion molecule‐1 (PECAM‐1), glycoprotein (GP)Ibα, P‐selectin, CD63 and GPIIb/IIIa as well as the production of intraplatelet reactive oxygen species (ROS) were quantified by flow cytometry. Aggregation capacity was evaluated by aggregometry. Results The surface expression level of P‐selectin and GPIbα on platelets was decreased in bleeders (P‐selectin: 465±72U; GPIbα: 435±41U) compared to non‐bleeders (P‐selectin: 859±115U,p<0.01; GPIbα: 570±49U,p=0.04). Additionally, the mean fluorescence intensity of ADP‐stimulated P‐selectin and PECAM‐1 expressing platelets were reduced in bleeders (P‐selectin: 944±84U; PECAM‐1: 6,722±419U) compared to non‐bleeders (P‐selectin: 1,269±130U,p=0.04; PECAM‐1: 8,542±665U,p=0.03). Bleeders showed a higher amount of ROS formation in platelets (88.0±2.6%) than non‐bleeders (81.5±2.1%,p=0.05). Conclusions These findings suggested that changes of three platelet receptors (GPIbα, P‐selectin, and PECAM‐1) and elevated oxidative stress may play a role in patients with bleeding complications following LVAD implantation. These results might help to explain the high incidence of spontaneous hemorrhage during LVAD support through an altered platelet function.

Verified
Journal Article
Open access
PDF file
KKKristin Klaeske
Kristin Klaeske
AMAnna L. Meyer
Anna L. Meyer
DSDiyar Saeed
Diyar Saeed
SESandra Eifert
Sandra Eifert
KJKhalil Jawad
Khalil Jawad
MDMaja-Theresa Dieterlen
Maja-Theresa Dieterlen
Non-surgical bleeding (NSB) is one of the major clinical complications in patients under continuous-flow left ventricular assist device (LVAD) support. The increased shear stress leads to an altered platelet receptor composition. Whether these changes increase the risk for NSB is unclear. Thus, we compared the platelet receptor composition of patients with (bleeder group, n = 18) and without NSB (non-bleeder group, n = 18) prior to LVAD implantation. Blood samples were obtained prior to LVAD implantation and after bleeding complications in the post-implant period. Platelet receptor expression of GPIbα, GPIIb/IIIa, P-selectin and CD63 as well as intra-platelet oxidative stress levels were quantified by flow cytometry. Bleeders and non-bleeders were comparable regarding clinical characteristics, von Willebrand factor diagnostics and the aggregation capacity before and after LVAD implantation (p > 0.05). LVAD patients in the bleeder group suffered from gastrointestinal bleeding (33%; n = 6), epistaxis (22%; n = 4), hematuria or hematoma (17%; n = 3, respectively) and cerebral bleeding (11%; n = 2). Prior to LVAD implantation, a restricted surface expression of the platelet receptors P-selectin and GPIIb/IIIa was observed in the bleeder group (P-selectin: 7.2 ± 2.6%; GPIIb/IIIa: 26,900 ± 13,608 U) compared to non-bleeders (P-selectin: 12.4 ± 8.1%, p = 0.02; GPIIb/IIIa: 36,259 ± 9914 U; p = 0.02). We hypothesized that the reduced platelet receptor expression of P-selectin and GPIIb/IIIa prior to LVAD implantation may be linked to LVAD-related NSB.

Verified
Journal Article
Open access
PDF file
KKKristin Klaeske
Kristin Klaeske
ABAnneke Brade
Anneke Brade
SESandra Eifert
Sandra Eifert
KJKhalil Jawad
Khalil Jawad
DSDiyar Saeed
Diyar Saeed
MDMaja-Theresa Dieterlen
Maja-Theresa Dieterlen
Non-surgical bleeding (NSB) remains the most critical complication in patients under left ventricular assist device (LVAD) support. It is well known that blood exposed to high shear stress results in platelet dysfunction. Compared to patients without NSB, decreased surface expression of platelet receptor GPIbα was observed in LVAD patients with NSB. In this study, we aimed to compare the expression level of glycoprotein (GP)Ib-IX-V platelet receptor complex in HeartMate 3 (HM 3) patients with and without bleeding complications to investigate the alterations of the platelet transcriptomic profile on platelet damage and increased bleeding risk. Blood samples were obtained from HM 3 patients with NSB (bleeder group, n = 27) and without NSB (non-bleeder group, n = 55). The bleeder group was further divided into patients with early NSB (bleeder ≤ 3 mo, n = 19) and patients with late NSB (bleeder > 3 mo, n = 8). The mRNA and protein expression of GPIbα, GPIX and GPV were quantified for each patient. Non-bleeder, bleeder ≤ 3 mo and bleeder > 3 mo were comparable regarding the mRNA expression of GPIbα, GPIX and GPV (p > 0.05). The protein analysis revealed a significantly reduced expression level of the main receptor subunit GPIbα in bleeders ≤ 3 mo (p = 0.04). We suggest that the observed reduction of platelet receptor GPIbα protein expression in patients who experienced their first bleeding event within 3 months after LVAD implantation may influence platelet physiology. The alterations of functional GPIbα potentially reduce the platelet adhesion capacities, which may lead to an impaired hemostatic process and the elevated propensity of bleeding in HM 3 patients.